Vasovagal response secondary to permanent contraception device in pulmonary arterial hypertension

Abstract

Adequate contraception is an essential component of managing pulmonary hypertension in women of childbearing age. Intrauterine devices are a popular contraceptive choice for many women but are associated with a risk of vagal response upon placement in certain patients with pulmonary hypertension, which may not be well tolerated. More recently, newer permanent contraception devices have emerged in the market, such as the Essure. We describe the first case, to our knowledge, of vagal-associated response due to an Essure device placement.

 

Read the full article online

Topics

Cardiovascular Congenital Malformations
Gender Differences in Pulmonary Vascular Disease
Pulmonary Arterial Hypertension

Authors

Ali Ataya, Jessica Cope, Hassan Alnuaimat

Published in:

Pulmonary Circulation Vol 5: No 4 cover image

December 2015

Pulmonary Circulation Vol 5: No 4

View this journal

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI
standard-example-image.jpg